2023-11169. Bulk Manufacturer of Controlled Substances Application: Veranova, L.P.  

  • Start Preamble

    AGENCY:

    Drug Enforcement Administration, Justice.

    ACTION:

    Notice of application.

    SUMMARY:

    Veranova, L.P. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

    DATES:

    Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 24, 2023. Such persons may also file a written request for a hearing on the application on or before July 24, 2023.

    ADDRESSES:

    The Drug Enforcement Administration requires that all comments be submitted electronically through the Federal eRulemaking Portal, which provides the ability to type short comments directly into the comment field on the web page or attach a file for lengthier comments. Please go to https://www.regulations.gov and follow the online instructions at that site for submitting comments. Upon submission of your comment, you will receive a Comment Tracking Number. Please be aware that submitted comments are not instantaneously available for public view on https://www.regulations.gov. If you have received a Comment Tracking Number, your comment has been successfully submitted and there is no need to resubmit the same comment.

    End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    In accordance with 21 CFR 1301.33(a), this is notice that on March 27, 2023, Veranova, L.P., 2003 Nolte Drive, West Deptford, New Jersey 08066–1727, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substance(s):

    Controlled substanceDrug codeSchedule
    Gamma Hydroxybutyric Acid2010I
    Marihuana7360I
    Tetrahydrocannabinols7370I
    Dihydromorphine9145I
    Difenoxin9168I
    Amphetamine1100II
    Methamphetamine1105II
    Lisdexamfetamine1205II
    Methylphenidate1724II
    Nabilone7379II
    4-Anilino-N-Phenethyl-4-Piperidine (ANPP)8333II
    Norfentanyl (N-phenyl-N-(piperidin-4-yl) propionamide)8366II
    Cocaine9041II
    Codeine9050II
    Dihydrocodeine9120II
    Oxycodone9143II
    Dihydromorphine9145II
    Hydromorphone9150II
    Diphenoxylate9170II
    Ecgonine9180II
    Hydrocodone9193II
    Levorphanol9220II
    Meperidine9230II
    Methadone9250II
    Methadone intermediate9254II
    Morphine9300II
    Thebaine9333II
    Opium tincture9630II
    Oxymorphone9652II
    Noroxymorphone9668II
    Alfentanil9737II
    Remifentanil9739II
    Sufentanil9740II
    Tapentadol9780II
    Fentanyl9801II

    The company plans to bulk manufacture the listed controlled substances for the internal use intermediates for sale to its customers. In reference to drug codes 7360 (Marihuana), and 7370 (Tetrahydrocannabinols), the company plans to bulk manufacture these drugs as synthetic. No other activities for these drug codes are authorized for this registration.

    Start Signature

    Matthew Strait,

    Deputy Assistant Administrator.

    End Signature End Supplemental Information

    [FR Doc. 2023–11169 Filed 5–24–23; 8:45 am]

    BILLING CODE P

Document Information

Published:
05/25/2023
Department:
Drug Enforcement Administration
Entry Type:
Notice
Action:
Notice of application.
Document Number:
2023-11169
Dates:
Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may submit electronic comments on or objections to the issuance of the proposed registration on or before July 24, 2023. Such persons may also file a written request for a hearing on the application on or before July 24, 2023.
Pages:
33907-33907 (1 pages)
Docket Numbers:
Docket No. DEA-1193
PDF File:
2023-11169.pdf